Navigation Links
Kendle Appoints Pierre Geoffroy, MD, CM, MSc, FCFP Vice President, Early Stage
Date:6/7/2011

on des Medecins du Quebec, the College of Family Physicians of Canada, the Medical Council of Canada and the College of Physicians and Surgeons of Ontario.  He was awarded a fellowship in the College of Family Physicians of Canada in 1995.

Kendle has more than 25 years of experience in conducting Early Stage studies for more than 170 customers worldwide.  The Company's Early Stage operations consist of an 86-bed state-of-the-art inpatient unit in Toronto and a bioequivalence unit in Morgantown, W.Va. with bed space for 118 patients, allowing up to five bioequivalence studies to be conducted simultaneously.  The Toronto unit is experienced across all therapeutic areas and recognized internationally by global regulatory authorities for its expertise in conducting human abuse liability studies.  The unit houses the world's largest database of recreational drug users, ensuring that study participants can be enrolled rapidly and efficiently into these unique studies.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry.  Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing products to market for the benefit of patients worldwide.  As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

For more information, please visit www.kendle.com.

Forward Looking Statements

This press release contains forward-looking
'/>"/>

SOURCE Kendle International Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kendle Appoints Robert Shepard, MD, FACP Executive Director, Oncology
2. Kendle Rated a "Top CRO to Work With" for Fifth Consecutive Year
3. Kendle Announces Postponement of 2011 Annual Meeting
4. INC Research to Acquire Kendle International for $15.25 per Share in Cash
5. Kendle Chairman and CEO Receives Lifetime Achievement Award at Cincinnati USA Innovation Awards
6. Kendle Executives to Share Insights at 20th Annual Partnerships in Clinical Trials Conference
7. Kendle Announces Fourth Quarter and Full-Year 2010 Results
8. Kendle Appoints Martha Feller, PhD, Vice President and Global Head, Study Start-up
9. Kendle Announces CEO Succession Plan, Promotes Stephen Cutler, PhD, to President and CEO
10. Kendle to Present at Lazard Capital Markets 7th Annual Healthcare Conference
11. Kendle Announces Details Regarding Third Quarter 2010 Earnings Conference Call and Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014 Orexigen® Therapeutics, ... results for the second quarter 2014, on Thursday, August ... followed by a live webcast and conference call at ... Orexigen management will host the call and webcast ... live call may be accessed by calling (800) 708-4540 ...
(Date:7/31/2014)... 31 2014  Northsight Capital, Inc. (OTCBB: NCAP) announced today ... Chairman and CEO of the company. Mr. Bluher has ... business development and investment banking. Mr. Bluher has over ... his career on Wall Street, Mr. Bluher was also ... Securities and Exchange Commission in Washington D.C. ...
(Date:7/31/2014)... International plc (NASDAQ: ENDP ) (TSX: ENL) ... an increase of 1 percent compared to second quarter ... of $21 million in the second quarter 2014 compared ... quarter of 2013.  As detailed in the supplemental financial ... ended June 30, 2014 increased by 4 percent to $174 ...
Breaking Medicine Technology:Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast 2Northsight Capital, Inc. Names Wall Street Veteran John Bluher, Former EVP And General Counsel Of Knight Trading Group, Chairman And CEO. 2Endo Reports Second Quarter Financial Results 2Endo Reports Second Quarter Financial Results 3Endo Reports Second Quarter Financial Results 4Endo Reports Second Quarter Financial Results 5Endo Reports Second Quarter Financial Results 6Endo Reports Second Quarter Financial Results 7Endo Reports Second Quarter Financial Results 8Endo Reports Second Quarter Financial Results 9Endo Reports Second Quarter Financial Results 10Endo Reports Second Quarter Financial Results 11Endo Reports Second Quarter Financial Results 12Endo Reports Second Quarter Financial Results 13Endo Reports Second Quarter Financial Results 14Endo Reports Second Quarter Financial Results 15Endo Reports Second Quarter Financial Results 16Endo Reports Second Quarter Financial Results 17Endo Reports Second Quarter Financial Results 18Endo Reports Second Quarter Financial Results 19Endo Reports Second Quarter Financial Results 20Endo Reports Second Quarter Financial Results 21Endo Reports Second Quarter Financial Results 22Endo Reports Second Quarter Financial Results 23Endo Reports Second Quarter Financial Results 24Endo Reports Second Quarter Financial Results 25Endo Reports Second Quarter Financial Results 26Endo Reports Second Quarter Financial Results 27Endo Reports Second Quarter Financial Results 28Endo Reports Second Quarter Financial Results 29Endo Reports Second Quarter Financial Results 30Endo Reports Second Quarter Financial Results 31Endo Reports Second Quarter Financial Results 32
... issued in 2007 with the intent to procure an MVA-based,third ... of the Canadian Department of National Defence, has awarded,a contract ... The Canadian authorities intend to ... The contract provides for the ...
... DIEGO, Dec. 1 Vical Incorporated (Nasdaq: VICL ... payment from Merck & Co., Inc. based on Merck,s planned ... plasmid DNA (pDNA) cancer vaccine. The candidate vaccine is based ... reverse transcriptase (hTERT). hTERT is the subject of separate license ...
Cached Medicine Technology:The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 2The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Country's Biological Preparedness 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2
(Date:7/31/2014)... 2014 Jacuzzi Luxury Bath, ... has launched a new and improved website to meet ... The Jacuzzi Luxury Bath website has been redesigned to ... and quality represented by the company’s products. The design ... and inspirational bathroom applications. “The site reflects our Jacuzzi® ...
(Date:7/31/2014)... believed to be the largest genetic analysis of what ... common childhood blood cancer, researchers at NYU Langone Medical ... drug target for treating the disease. , T-cell ... and aggressive childhood blood cancers. An estimated quarter of ... cancer each year in the U.S. fail to achieve ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 David ... Inc. ( http://www.maxlifesolution.com ) is thrilled that the ... patterns using proprietary Artificial Intelligence (AI) algorithms and ... has finally gained acceptance. , “It ... dollars, but the proof is in," said Kekich. ...
(Date:7/31/2014)... The North American Colorants Market report defines ... with analysis and forecast of volume growth. , ... Colorants Market report, to get an idea of ... glimpse of the segmentation in the North American ... and figures. , http://www.micromarketmonitor.com/market/americas-colorants-8463333110.html , ...
(Date:7/31/2014)... York, NY (PRWEB) July 31, 2014 ... Ovarian Cancer Coalition will be featured in the ... space is being donated by EHE International, an ... care management. The eye-catching window display, designed in ... flip-flops symbolizing women’s footsteps, in a ratio that ...
Breaking Medicine News(10 mins):Health News:Jacuzzi Luxury Bath Launches New and Improved Website 2Health News:Drug target identified for common childhood blood cancer 2Health News:Drug target identified for common childhood blood cancer 3Health News:MaxLife Solution™ Expands Distribution Globally for Breakthrough Anti-Inflammatory Support Supplement – InflaGene™ 2Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 2Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 3Health News:Americas Colorants Market is Expected to Reach 2,006 Thousand MT in 2018 - New Report by MicroMarket Monitor 4Health News:National Ovarian Cancer Coalition to be Featured in New York’s Rockefeller Center Window during August to Raise Awareness and Promote Education about Ovarian Cancer 2Health News:National Ovarian Cancer Coalition to be Featured in New York’s Rockefeller Center Window during August to Raise Awareness and Promote Education about Ovarian Cancer 3
... FRIDAY, June 24 (HealthDay News) -- A new study ... or nude photos over the Internet -- is now a ... notoriously cost former Democratic Congressman Anthony Weiner his job, is ... lead author. In fact, she said, it,s a part of ...
... June 24, 2011David Satcher, MD, PhD, former U.S. Surgeon General, ... child and adult health that we are facing today," calling ... editorial in the June issue of Childhood Obesity , ... editorial is available online. A long-time advocate in ...
... drug used by patients with type 2 diabetes improved their ... Southwestern Medical Center. The study findings, reported in today,s ... time a drug therapy has led to improved kidney function ... Previous studies have identified drugs that slowed the deterioration of ...
... HealthDay Reporter , THURSDAY, June 23 (HealthDay News) -- After ... their hopes and fears about the future are less depressed ... In fact, 48 percent of the people who ... a stroke were not depressed a year later, compared to ...
... increased the advertising and lowered the sale price of ... larger populations of African-American students, according to a new ... cigarette makers have denied using race or ethnicity to ... the data shows a "predatory" marketing pattern geared to ...
... vessels and supporting cells appear to be pivotal partners ... their partnership with nerve cells might make the difference ... damaged nerves, Johns Hopkins researchers report in a new ... a painful tingling, burning or numbness in the hands ...
Cached Medicine News:Health News: 'Sexting' Common for Those Who Cheat: Study 2Health News: 'Sexting' Common for Those Who Cheat: Study 3Health News:Drug shows improved kidney function for type 2 diabetics, UT Southwestern researchers report 2Health News:Early Talk Therapy May Help Stroke Patients Bounce Back 2Health News:Early Talk Therapy May Help Stroke Patients Bounce Back 3Health News:Menthol cigarettes marketed in 'predatory' pattern, Stanford study shows 2Health News:Menthol cigarettes marketed in 'predatory' pattern, Stanford study shows 3Health News:To fix diabetic nerve damage, blood vessels and support cells may be the real targets of treatment 2
... MDS display system provides maximum impact for ... This unique approach to displaying frames allows ... and create appealing, flexible and eye-catching displays. ... and your patients are motivated. Removable holders. ...
A pre-assembled, hexagonal, revolving tower display with two round 19.75" in diameter adjustable shelves. Enjoy 3.5 square feet of elegant shelf space for your products....
A pre-assembled, rectangular shadow box/wall hanging display. It have 3 adjustable shelves with tempered glass, four 50 watt halogen top lights, laminated deck, dust resistant and electrical cord wit...
Classic is proud to provide top-quality vision eyewear to physicians, health maintenance organizations (HMOs), and numerous state and federal government programs. Classic Laboratory produces over 150...
Medicine Products: